Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
3. St. Jude Medical slides on negative results from heart implant trial
St. Jude Medical shares are down 4% today after clinical trial results show no significant benefit from its Amplatzer heart implant.
2. McKesson to pay $2B for PSS World Medical
McKesson agrees to pony up more than $2 billion for medical supplies provider PSS World Medical.
1. Senate report blasts Medtronic over Infuse bone protein
A report by the U.S. Senate’s Finance Committee blasts Medtronic over its Infuse bone morphogenetic protein, saying the company deliberately schemed to suppress evidence of adverse effects and promoted off-label use.
